Cancer Research Infection and Cancer: Biology, Therapeutics, and Prevention
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 45, 181-185, January 1, 1985]
© 1985 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Li, S. A.
Right arrow Articles by Li, J. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Li, S. A.
Right arrow Articles by Li, J. J.

Estrogen 2- and 4-Hydroxylase Activity, Catechol Estrogen Formation, and Implications for Estrogen Carcinogenesis in the Hamster Kidney1

Sara Antonia Li, John K. Klicka and Jonathan J. Li2

Medical Research Laboratories, Veterans Administration Medical Center [J. J. L.], and Department of Urologic Surgery [S. A. L., J. K. K., J. J. L.], University of Minnesota Medical School, Minneapolis, Minnesota 55455

Estrogen 2- and 4-hydroxylase (ESH), a microsomal enzyme which mediates the formation of catechol estrogens, has been studied in the kidneys of castrated male Syrian hamsters, a species uniquely susceptible to induction of renal carcinomas by both steroidal and stilbene estrogens. The apparent Km for estrone was 17.0 µM, and Vmax was 0.5 pmol per mg protein per min for ESH in renal microsomes derived from castrated hamsters. Different steroidal estrogen substrates exhibited decreasing catechol formation with hamster kidney microsomal preparations in the following order: estrone > d-equilenin > 17ß-estradiol > equilin > ethynyl estradiol > estriol. Except for ß-dienestrol, the stilbene estrogens revealed levels of catechol formation that were similar to 17ß-estradiol. These findings provide a rationale for the weak carcinogenic activity of ethynyl estradiol, estriol, and ß-dienestrol, since they were poor substrates for hamster renal ESH and for the relatively potent carcinogenic activity of the distal metabolite of diethylstilbestrol, indenestrol B/A, which exhibited substantial levels of o-hydroxylation when used as a substrate. Interestingly, ESH activity was significantly greater in the hamster kidney compared to corresponding rat tissue, and catechol estrogen formation was found to be 2.5- to 19-fold higher in the hamster kidney compared to the rat, using various steroidal and stilbene estrogen substrates. Moreover, the finding that a 3.5- to nearly 6-fold decrease, compared to untreated levels, in catechol formation in kidneys but not in livers of {alpha}-naphthoflavone-exposed hamsters, depending on the steroidal or stilbene estrogen substrate used, is consistent with the belief that the catechol estrogen pathway is pertinent to events leading to estrogen-induced renal tumorigenesis in the hamster.

1 This investigation was supported by Grant CA 22008 from the National Cancer Institute, NIH, Department of Health and Human Services; Grant 1K07 ES00094 from the National Institute of Environmental Health Sciences, NIH, Department of Health and Human Services; and the General Medical Research Fund of the Veterans Administration. Presented in part at the 65th Annual Meeting of the Endocrine Society, San Antonio, TX, June 8 to 10, 1983 (12).

2 To whom requests for reprints should be addressed, at Medical Research Laboratories, Bldg. 49, Veterans Administration Medical Center, 54th Street and 48th Avenue South, Minneapolis, MN 55417.

Received 5/ 7/84. Accepted 9/27/84.




This article has been cited by other articles:


Home page
Proc. Natl. Acad. Sci. USAHome page
H. K. Bhat, G. Calaf, T. K. Hei, T. Loya, and J. V. Vadgama
Critical role of oxidative stress in estrogen-induced carcinogenesis
PNAS, April 1, 2003; 100(7): 3913 - 3918.
[Abstract] [Full Text] [PDF]


Home page
J Natl Cancer Inst MonogrHome page
J. D. Yager
Chapter 3: Endogenous Estrogens as Carcinogens Through Metabolic Activation
J Natl Cancer Inst Monographs, July 1, 2000; 2000(27): 67 - 73.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
J. G. Liehr
Is Estradiol a Genotoxic Mutagenic Carcinogen?
Endocr. Rev., February 1, 2000; 21(1): 40 - 54.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1985 by the American Association for Cancer Research.